
Formosa Pharmaceutical and Sarval Corporation announced licensing agreement for the Suspension of Cletasolol in Ophthalmic Suspension for the treatment of post-operative disease
Source link
Client Challenge
Client Challenge JavaScript is disabled in your browser. Please enable JavaScript to continue. A required part of this site could not load. This could be due to a browser extension,…





